Med-botics, a firm based in Colorado Springs, won FDA Breakthrough Device status for its Oxalert EPO (Enhanced Pulse Oximeter), a device developed to prevent respiratory arrest from opioid overdoses.
Post-op patients and others on heavy opioid therapy can stop breathing, which can lead to death if not monitored carefully. The Oxalert EPO mo (Read more...)